Mild Topical Corticosteroid
Pregnancy: Compatible for short-term use on small area
Hydrocortisone (Topical)
Brand names: Hc45, Dioderm
Adult dose
Dose: Apply thinly OD–BD
Route: Topical
Frequency: OD–BD
Max: Apply minimum effective amount
Mildest potency class. Safe for face, flexures, and infants. Hydrocortisone 1% OTC available.
Paediatric dose
Route: Topical
Frequency: OD–BD
Max: See FTU guidance
Concentration: 0.5%, 1%, 2.5% FTU/ml
Safe for face in infants ≥3 months. FTU: 1 FTU (fingertip unit) per 2 palms-worth of skin.
Dose adjustments
Renal
N/A
Hepatic
N/A
Clinical pearls
- FTU guidance: fingertip unit (FTU) from adult index finger tip to first crease = 0.5 g, covers 2 adult hand-palms
- Safe for face, flexures, genitalia, infants — not stronger steroids
- OTC availability (1%): patients self-prescribing — confirm appropriate use
Contraindications
- Infected lesions without cover
- Acne rosacea
- Perioral dermatitis
Side effects
- Skin atrophy (with prolonged use)
- Striae
- Telangiectasia
- Contact sensitisation (rare)
Interactions
- Systemic corticosteroid effects (minimal with mild topical at small area)
Monitoring
- Skin atrophy
- Extent of spread
Reference: BNFc; BNF; NICE NG190 Atopic Eczema; British Association of Dermatology (BAD) Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD